Axis Bank rating – Overweight- Turnaround likely to gain pace over 3 years
时间:2024-05-18 12:43:55 阅读(143)
A Good turnaround has been under way for Axis Bank over the past three years – asset quality has turned, granularity has improved, distribution has expanded and growth is now accelerating. Axis Bank has a) significantly tightened underwriting practices, reduced risk in corporate banking and improved provisioning coverage; b) improved granularity across key metrics – fees, loans, and deposits; c) strengthened digital banking initiatives and expanded its distribution capabilities; d) increased investments in higher margin business (where growth has now accelerated); and e) generated significant value in subs. as part of one Axis initiative.
The next big deliverable will be retail deposit growth, which could improve operating profit growth on a sustainable basis: Although Axis has seen a pickup in CASA, retail deposit momentum has been subdued. Apart from lower rates, this has been driven by reclassification of retail term deposits from ‘size’ based classification to ‘ownership’ based, and could weigh on retail deposit growth momentum for next 2-3 quarters. That said, the bank has increased investments in payments, wealth management, and corporate salary accounts, and is gaining good traction. This, coupled with an improving macro and rising rates, should help accelerate retail deposits by late FY23 onward, in our view.
Attractive risk reward: Core valuations appear attractive at 1.35x FY23/1.2x FY24 book, and do not seem to be fully pricing in the structural improvement, we believe (RoE of ~16% seen by FY25, vs. 12% in FY22). We value the bank at 1.7x book, implying >35% upside. Our price target of Rs 910 remains unchanged. Key risks: slower than expected improvement in the liability franchise and/or significant attrition in Citi’s retail client and employee base (if the proposed acquisition is approved).
上一篇:SC to hear RIL’s contempt petition against Sebi today
下一篇:Year Ahead- Lower interest rates may buoy affordable housing in 2024
猜你喜欢
- Boehringer Ingelheim, Kyowa Kirin enter license agreement to develop novel treatment for fibro-inflammatory diseases
- Q1 earnings, global cues, FII to influence trading in equities this week- Analysts
- Bournvita row- Cadbury reduces added sugar by around 15 percent from its popular health drink after backlash
- Bitcoin topped $45,000 for first time in nearly two years
- PSU banks rally on bond inclusion hopes
- Blue Jet Healthcare’s IPO subscribed 7
- BofA cuts year-end Nifty target to 14,500
- Sebi nod for future contracts on corporate bond indices
- Pro-Kannada groups run riot in Bengaluru over order to use ‘60% Kannada’ signages